MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231
T细胞淋巴母细胞淋巴瘤诱导治疗结束时的微小残留病灶(MRD)和无事件生存期(EFS):儿童肿瘤协作组试验AALL1231
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2023021184
Hayashi, Robert J; Hermiston, Michelle L; Wood, Brent L; Teachey, David T; Devidas, Meenakshi; Chen, Zhiguo; Annett, Robert D; Asselin, Barbara L; August, Keith; Cho, Steve; Dunsmore, Kimberly P; Freedman, Jason Lawrence; Galardy, Paul J; Harker-Murray, Paul; Horton, Terzah M; Jaju, Alok; Lam, Allison; Messinger, Yoav H; Miles, Rodney R; Okada, Maki; Patel, Samir; Schafer, Eric S; Schechter, Tal; Shimano, Kristin A; Singh, Neelam; Steele, Amii; Sulis, Maria L; Vargas, Sarah L; Winter, Stuart S; Wood, Charlotte; Zweidler-McKay, Patrick A; Loh, Mignon L; Hunger, Stephen P; Raetz, Elizabeth A; Bollard, Catherine M; Allen, Carl E
肿瘤
T细胞
肿瘤免疫
淋巴瘤
T细胞
细胞生物学
免疫/内分泌